Ethicists have raised concerns that elderly patients with a progressively debilitating disease such as Parkinson's disease (PD) may be too vulnerable for research that involves novel, invasive interventions (such as gene transfer and cell transplants) that use a controversial masking design, i.e., sham neurosurgical controls. A common ethical concern is that the subjects'desire for therapeutic benefit may compromise the quality of their decisions. Are these subjects laboring under a therapeutic misconception (TM), a phenomenon in which subjects conflate research with individualized treatment, or some related phenomena, e.g., seriously misestimating the risks and benefits of research participation? There is an increasing number of PD clinical trials proposing the sham control design, so this important ethical issue will continue to arise. This project proposes to study enrollees and decliners of four actual PD neurosurgical clinical trials that involve a sham surgery control. Because there is no standard method for assessing TM and indeed because it remains a controversial and evolving issue, this project's main aim is to describe in depth from the subjects'perspective their decision whether to participate in such studies. A semi-structured interview method (Conditional Probe Interview) has been developed to provide an in depth account of the subjects'motivations, expectations, understanding, and decision-making process-emphasizing the subjects'rationale for each and the relationship between them. We will conduct a combination of prospective and retrospective interviews;those subjects who decline after screening interviews will also be interviewed. Enrollees of the trials will also be followed longitudinally, so any changes in motivations, attitudes, or understanding can be assessed. A unique focus of this project is that the analysis will emphasize the entirety of the subject's narrative as the context for analyzing specific statements that may or may not indicate TM related phenomena. Thus, the subject becomes the primary unit of analysis in the interpretation of individual statements. A complementary qualitative and quantitative analytic approach will be used. By providing an in depth, context-sensitive account of how seriously ill neurological patients make participation decisions regarding research involving sham neurosurgery controls, this project will (1) provide invaluable insights for optimizing informed consent practices for future sham surgery controlled trials;and (2) clarify the key controversial aspects, and the complex contours of, TM and related phenomena.

Public Health Relevance

This project addresses the ethical challenges of human subject research when subjects with serious illnesses are enrolled in clinical trials involving sham surgery controls. In particular, it will enhance the mission of NINDS by focusing on the ethics of sham surgery controls in Parkinson's disease neurosurgical trials-a design that is increasingly used in testing novel surgical interventions for PD. Specifically, the results of this study will provide important insights into how to minimize or even eliminate serious misconceptions or misunderstandings on the part of participants that may compromise the quality of their consent.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS062770-03
Application #
8026012
Study Section
Special Emphasis Panel (ZRG1-HOP-Z (90))
Program Officer
Odenkirchen, Joanne
Project Start
2009-03-01
Project End
2013-02-28
Budget Start
2011-03-01
Budget End
2012-02-29
Support Year
3
Fiscal Year
2011
Total Cost
$328,408
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Psychiatry
Type
Schools of Medicine
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Kim, Scott Yh; Wilson, Renee; De Vries, Raymond et al. (2016) Are patients with amyotrophic lateral sclerosis at risk of a therapeutic misconception? J Med Ethics 42:514-8
Kim, Scott Y H; Wilson, Renee; De Vries, Raymond et al. (2015) ""It is not guaranteed that you will benefit"": True but misleading? Clin Trials 12:424-9
Kim, Scott Y H; Wilson, Renee; De Vries, Raymond et al. (2015) Could the High Prevalence of Therapeutic Misconception Partly Be a Measurement Problem? IRB 37:11-8
Kim, Scott Y H; De Vries, Raymond; Parnami, Sonali et al. (2015) Are therapeutic motivation and having one's own doctor as researcher sources of therapeutic misconception? J Med Ethics 41:391-7
Wilson, Renee; Kieburtz, Karl; Holloway, Robert G et al. (2014) Evidence-based research ethics and determinations of ""engagement in research"". IRB 36:10-3
Kim, Scott Y H; de Vries, Raymond; Wilson, Renee et al. (2013) Research participants' ""irrational"" expectations: common or commonly mismeasured? IRB 35:1-9
Kim, Scott Y H; Wilson, Renee M; Kim, H Myra et al. (2012) Comparison of enrollees and decliners of Parkinson disease sham surgery trials. Mov Disord 27:506-11
Kim, Scott Y H; De Vries, Raymond; Holloway, Robert G et al. (2012) Sham surgery controls in Parkinson's disease clinical trials: views of participants. Mov Disord 27:1461-5
Kim, Scott Y H; Holloway, Robert G (2010) Is it research?: an increasingly common question. Neurology 75:102-4
Kim, Scott Y H; Schrock, Lauren; Wilson, Renee M et al. (2009) An approach to evaluating the therapeutic misconception. IRB 31:7-14